Terms: = Breast cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Treatment
62844 results:
1. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
Qi G; Zhang X; Gai X; Yan X
PeerJ; 2024; 12():e17377. PubMed ID: 38766488
[TBL] [Abstract] [Full Text] [Related]
2. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
[TBL] [Abstract] [Full Text] [Related]
3. [Fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting in breast cancer: a randomized controlled trial].
Chen Q; Lei Y; Bai S; Luo X; Lei X; Chen Y; Li D
Zhongguo Zhen Jiu; 2024 May; 44(5):526-30. PubMed ID: 38764102
[TBL] [Abstract] [Full Text] [Related]
4. Effect of gradient pressure therapy on the prevention of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Dongxue G; Fangfei Z; Ran L; Lizhi Z
Support Care Cancer; 2024 May; 32(6):367. PubMed ID: 38761270
[TBL] [Abstract] [Full Text] [Related]
5. A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.
Bounous VE; Cipullo I; D'Alonzo M; Martella S; Franchi D; Villa P; Biglia N; Ferrero A
Gynecol Endocrinol; 2024 Dec; 40(1):2334796. PubMed ID: 38760920
[TBL] [Abstract] [Full Text] [Related]
6. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
Boutrus RR; Abdelazim YA; Mohammed T; Bayomy M; Ibraheem MH; Hussein A; Sebaie ME
BMC Cancer; 2024 May; 24(1):599. PubMed ID: 38760780
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
8. Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.
Rajan KK; Fairhurst K; Birkbeck B; Novintan S; Wilson R; Savović J; Holcombe C; Potter S
BJS Open; 2024 May; 8(3):. PubMed ID: 38758563
[TBL] [Abstract] [Full Text] [Related]
9. Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early breast cancer.
Rinder P; Marcille T; Sinel-Boucher P; Cals-Maurette M; Kanoun D; Levy C; Teixeira L; Hornus P; Szeftel D; Heudel PE
JAMA Netw Open; 2024 May; 7(5):e2411909. PubMed ID: 38758553
[TBL] [Abstract] [Full Text] [Related]
10. D-arabinose induces cell cycle arrest by promoting autophagy via p38 MAPK signaling pathway in breast cancer.
Tang Z; Song H; Qin S; Tian Z; Zhang C; Zhou Y; Cai R; Zhu Y
Sci Rep; 2024 May; 14(1):11219. PubMed ID: 38755221
[TBL] [Abstract] [Full Text] [Related]
11. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
12. Robotic assisted versus laparoscopic surgery for deep endometriosis: a meta-analysis of current evidence.
Pavone M; Baroni A; Campolo F; Goglia M; Raimondo D; Carcagnì A; Akladios C; Marescaux J; Fanfani F; Scambia G; Ianieri MM
J Robot Surg; 2024 May; 18(1):212. PubMed ID: 38753180
[TBL] [Abstract] [Full Text] [Related]
13. Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.
Hauner D; Mang A; Donik L; Schederecker F; Meyer D; Rack B; Janni W; Hauner H
BMC Cancer; 2024 May; 24(1):591. PubMed ID: 38750410
[TBL] [Abstract] [Full Text] [Related]
14. Practice of breast self-examination and associated factors among women of reproductive age in the North Shoa Zone, Oromia, Ethiopia, 2022: a convergent mixed-methods study.
Hussein D; Oyato BT; Gashaw K; Geleta TA; Tufa DG; Geleta LA
BMJ Open; 2024 May; 14(5):e073951. PubMed ID: 38749697
[TBL] [Abstract] [Full Text] [Related]
15. Exploration of poly (ADP-ribose) polymerase inhibitor resistance in the treatment of BRCA1/2-mutated cancer.
Wu S; Yao X; Sun W; Jiang K; Hao J
Genes Chromosomes Cancer; 2024 May; 63(5):e23243. PubMed ID: 38747337
[TBL] [Abstract] [Full Text] [Related]
16. The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.
Li BX; Wang YQ; Yi YY; Zhou N; Lv ZX; Ma R; Li X; Yuan N
BMC Public Health; 2024 May; 24(1):1309. PubMed ID: 38745323
[TBL] [Abstract] [Full Text] [Related]
17. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
[TBL] [Abstract] [Full Text] [Related]
18. FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs.
Gorska-Arcisz M; Popeda M; Braun M; Piasecka D; Nowak JI; Kitowska K; Stasilojc G; Okroj M; Romanska HM; Sadej R
Cell Mol Biol Lett; 2024 May; 29(1):71. PubMed ID: 38745155
[TBL] [Abstract] [Full Text] [Related]
19. An Immersive Virtual Reality Intervention for Preoperative Anxiety and Distress Among Adults Undergoing Oncological Surgery: Protocol for a 3-Phase Development and Feasibility Trial.
El-Gabalawy R; Sommer JL; Hebbard P; Reynolds K; Logan GS; Smith MSD; Mutter TC; Mutch WA; Mota N; Proulx C; Gagnon Shaigetz V; Maples-Keller JL; Arora RC; Perrin D; Benedictson J; Jacobsohn E
JMIR Res Protoc; 2024 May; 13():e55692. PubMed ID: 38743939
[TBL] [Abstract] [Full Text] [Related]
20. Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
Munter-Young R; Fuentes-Alburo A; DiGregorio N; Neeser K; Gultyaev D
PLoS One; 2024; 19(5):e0302486. PubMed ID: 38743917
[TBL] [Abstract] [Full Text] [Related]
[Next]
